Clinical trials
Hyperopia trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
101 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 3 |
| 2012 | 5 |
| 2013 | 10 |
| 2014 | 1 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 9 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 68 |
| Unknown status | 11 |
| Not yet recruiting | 7 |
| Recruiting | 5 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alcon Research | 17 |
| CooperVision, Inc. | 11 |
| CooperVision International Limited (CVIL) | 4 |
| Eye Hospital Pristina Kosovo | 4 |
| Bausch & Lomb Incorporated | 3 |
| EyeQue Corp. | 3 |
| Lentechs, LLC | 3 |
| Abbott Medical Optics | 2 |
| Essilor International | 2 |
| Ohio State University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperopia | 101 |
| Myopia | 69 |
| Refractive Errors | 30 |
| Astigmatism | 27 |
| Presbyopia | 15 |
| Amblyopia | 3 |
| Anisometropia | 3 |
| Pseudophakia | 3 |
| Alzheimer Disease | 1 |
| Asthenopia | 1 |
Trials
Showing 26 to 50 of 101. Each trial links to its page on Pharma Observatory.
1 more trial matches. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.